Exposure to Copper Oxide Nanoparticles Causes Human Infertility Risk and Damages the Quality of the Human Sperm Via the 5'Amp-Activated Protein Kinase-Mediated Signaling Pathway in Vitro

Weike Shaoyong,Bocheng Xu,Yalin Liu,Bo Pan,Yizhen Wang,Mingliang Jin
DOI: https://doi.org/10.2139/ssrn.4052477
2022-01-01
SSRN Electronic Journal
Abstract:The development of copper oxide nanoparticles (CuONPs) has accelerated their medical and technological applications owing to their unique physicochemical properties, which have concurrently raised concerns because of their potential hazards. Nanopollutants may have toxic effects on gametes and fertilization processes in species with external fertilization, thereby reducing the effectiveness of reproduction or greatly impairing it. The objective of the present study was to determine the effect of CuONPs on the quality of human spermatozoa and to reveal the potential molecular mechanisms. The sperm quality parameters, motility and movement parameters, antioxidant-related parameters, energy metabolism, and capacitation parameters were evaluated in CuONP-treated human sperm. The results showed that exposure to CuONPs substantially reduced the sperm quality parameters, motility and movement parameters, activities of enzymatic antioxidants [glutathione peroxidase (GPX), superoxide dismutase (SOD), and catalase (CAT)], energy metabolism, and capacitation parameters. Simultaneously, reactive oxygen species (ROS) and malondialdehyde (MDA) levels in human sperm were remarkably increased in the presence of CuONPs. The adverse effects of CuONPs on sperm were partly counteracted and completely reversed by NAC and the AMPK activator (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside), respectively. Mechanistically, CuONP exposure induced oxidative stress (OS) by attenuating the AMPK phosphorylation pathway, which is involved in activating enzymatic antioxidants, and by increasing the levels of ROS and MDA, thereby causing damage to sperm function-related parameters. Moreover, CuONP exposure reduced sperm capacitation via the OS-mediated cAMP/PKA signaling pathway, which resulted in decreased ATP levels by switching from oxidative phosphorylation to glycolysis, and inhibited the messenger cAMP synthesis. Eventually, the capacitation-related phosphorylation of PKA and tyrosine was downregulated. Taken together, we suggest that CuONPs cause sperm toxicity via the OS-mediated p-AMPK signaling pathway. The present study provides novel information on the molecular mechanism of CuONP-induced toxicity to human spermatozoa.
What problem does this paper attempt to address?